NEWS
Big pipeline, juicy margins remains GemLife’s IPO Pitch
            
            
BRISBANE: ASX aspirant GemLife says it has a bigger pipeline than $815 million listed rival… read more
Proxy advisers support Mayne Pharma deal despite bitter lawsuit
            
            
MELBOURNE: A legal dispute between Mayne Pharma and private equity suitor Cosette, which has terminated… read more










